Ultrajaya Milk (ULTJ IJ) is the leading dairy company in Indonesia. Its most popular product “Ultra Milk” has a market share of roughly 40% and dominates the mass market.
The company focuses on “UHT milk”. Such milk has been treated with ultra-high temperatures and stored in aseptic packaging, giving it a shelf life of 6-9 months at normal room temperatures. This makes UHT milk highly convenient. Especially in Indonesia given that the climate is tropical and the cold chain infrastructure is undeveloped.
Indonesia’s per capita consumption of milk is only 15 litres per year. That number can be compared with neighbouring Malaysia’s 60 litres. While most people in Asia consume dairy on a regular basis, that is not yet the case in Indonesia. I believe that the gap in milk consumption between Indonesia and its neighbouring countries will narrow over time.
Ultrajaya is run by founder Sabana Prawirawidjaja and his family. Under Sabana’s leadership, the company has grown roughly 10x over the past 15 years. I’m impressed by the company’s honest style of communication. They are tackling difficulties heads-on and readily admit any weakness.
If you want to fault them for anything, it would be for being too conservative. Ultrajaya issued medium-term notes at 7.5-8.5% interest rates at the height of the pandemic, despite plenty of cash on the balance sheet. They justified the action by saying that the uncertainty brought about by the pandemic necessitated additional caution.
On the plus side, Ultrajaya also repurchased 10% of its shares during the crisis. Founder Sabana Prawirawidjaja has also been buying shares for his personal account over the past few months.
The risks are probably manageable. Competition from the likes of Greenfields is heating up but Ultrajaya remains dominant. Import prices for raw milk will fluctuate due to a volatile Rupiah. Costs tend to be passed on to consumers within a few years. One might also question the no-name auditor and minority shareholdings in certain distributors. But the corporate structure is by no means unusual for a family-run business in an emerging market.
Assuming 10% initial top-line growth in line with guidance, some margin pressure due to the planned construction of new production and distribution facilities and a 20x P/E on 2024e earnings, the upside to intrinsic value in that scenario would be +72%.
If you have any questions about the stock, please ask a question in the comment section below. You can also follow the discussion on Twitter on the Asian Century Stocks members account @AsianCenturyStx.
Please click the picture below to access the full PowerPoint presentation:
Disclaimer: Asian Century Stocks uses information sources believed to be reliable, but their accuracy cannot be guaranteed. The information contained in this publication is not intended to constitute individual investment advice and is not designed to meet your personal financial situation. The opinions expressed in such publications are those of the publisher and are subject to change without notice. You are advised to discuss your investment options with your financial advisers. Consult your financial adviser to understand whether any investment is suitable for your specific needs. I may from time to time have positions in the securities covered in the articles on this website. Full disclosure: I do not hold a position in Ultrajaya at the time of publishing this article. This is disclosure and not a recommendation to buy or sell.
Thanks for reading, and I wish you a great week ahead!
If you enjoyed this post, please consider becoming a full subscriber of Asian Century Stocks by pressing the button below. You will then have immediate access to the archive of past articles, 20+ deep-dives per year, thematic industry reports and full disclosure of my personal Asia-focused portfolio.
Do you have any idea what other income in the income statements is? It's fairly significant - 97.4 billion Rupiah in 2020.
You seem to like milk a lot....might want to check out Greatview Aseptic Packaging: milk packaging in China, a cheaper version of tetra pak. Trading around a projected PE of 12. Jardine and Mengniu own some. Net cash, high dividend, low (medium?) growth.
Idea is from: http://www.globalstockpicking.com/category/greatview-aseptic/
Raw materials is 90% of COGS, so they are susceptible to inflation:
https://greatviewpack.com/site/assets/files/1405/e00468_3.pdf
If we expect to see inflation 'spikes' over the next decade, the main question would be how soon they are able to pass on raw material costs every time this happens.
I don't know the industry: the competition & barriers to entry.